IDEXX LABORATORIES INC /DE Common Stock Shares Outstanding

• IDEXX LABORATORIES INC /DE showed a decrease of -2.3% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from IDEXX LABORATORIES INC /DE's annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2014: 47.37 million shares | Q2 2015: 92.64 million shares | Q3 2015: 91.20 million shares | Q1 2018: 87.00 million shares | Q2 2018: 86.64 million shares | Q3 2018: 86.55 million shares | Q1 2019: 86.05 million shares | Q2 2019: 86.10 million shares | Q3 2019: 85.89 million shares | Q1 2020: 84.93 million shares | Q2 2020: 85.05 million shares | Q3 2020: 85.30 million shares | Q1 2021: 85.37 million shares | Q2 2021: 85.10 million shares | Q3 2021: 84.88 million shares | Q1 2022: 84.16 million shares | Q2 2022: 83.43 million shares | Q3 2022: 83.00 million shares | Q1 2023: 83.00 million shares | Q2 2023: 83.06 million shares | Q3 2023: 83.07 million shares | Q1 2024: 82.87 million shares | Q2 2024: 82.48 million shares | Q3 2024: 82.04 million shares | Q1 2025: 80.74 million shares | Q2 2025: 80.15 million shares | Q3 2025: 80.00 million shares.
• Over the full 9 years of available data (2017 to 2025), IDEXX LABORATORIES INC /DE's Common Stock Shares Outstanding has declined by 8.5%.
• Historical annual values: Fiscal year 2025: 79.71 million shares | Fiscal year 2024: 81.60 million shares | Fiscal year 2023: 83.03 million shares | Fiscal year 2022: 82.89 million shares | Fiscal year 2021: 84.56 million shares | Fiscal year 2020: 85.45 million shares | Fiscal year 2019: 85.47 million shares | Fiscal year 2018: 86.10 million shares | Fiscal year 2017: 87.10 million shares.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026